FDA’s OGD Takes Fight To COVID-19 With Half-Century Of Approvals
Six-Dozen First Generics Approved Last Year Including $3.3bn Tecfidera
The sixth annual report of the FDA’s Office of Generic Drugs covered a year dominated by the novel coronavirus pandemic – although first-time generic approvals and record levels of communication also featured prominently.
